SCHEMBL24310709

SCHEMBL24310709

Cc1ccccc1-c1nc(NSc2cnn(C)c2)nc(Oc2cccc(N3CCN(C)CC3)c2Cl)c1Cl

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 3/20 0.33
▸ DRD3 P35462 3/20 0.33
▸ IGF1R P08069 3/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ HTR1A P08908 1/20 0.31
▸ DRD4 P21917 1/20 0.31
▸ HTR2A P28223 1/20 0.31
▸ HTR2C P28335 1/20 0.31
▸ EGFR P00533 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ CYP1A2 P05177 2/20 0.31
▸ CYP3A4 P08684 2/20 0.31
▸ CYP2D6 P10635 2/20 0.31
▸ JAK2 O60674 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ MAP3K7 O43318 2/20 0.31
▸ HTR6 P50406 1/20 0.31
▸ AXL P30530 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310712 0.93 AXL (0.33) DRD2DRD3IGF1RHTR1ADRD4
SCHEMBL24310558 0.92 IGF1R (0.31) DRD2DRD3IGF1RPAK1
SCHEMBL24310404 0.92 TACR1 (0.33) DRD2DRD3IGF1RAXL
SCHEMBL24310089 0.92 DRD2 (0.35) DRD2DRD3IGF1RNPC1HTR1A
SCHEMBL24309899 0.91 NPC1 (0.33) DRD2DRD3IGF1RNPC1ALDH1A1
SCHEMBL24309539 0.90 TACR1 (0.32) DRD2DRD3IGF1R
SCHEMBL24309796 0.90 ALK (0.33) DRD2DRD3IGF1REGFR
SCHEMBL24309901 0.87 IGF1R (0.33) IGF1RJAK2MAP3K7MAP2K1
SCHEMBL24309916 0.86 EGFR (0.39) IGF1REGFRJAK2MAP4K1
SCHEMBL24310424 0.86 PDE2A (0.41) IGF1REGFRJAK2MAP3K7MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback